Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease.
Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease.
复制标题
β-淀粉样蛋白 (1-40) 肽和亚临床心血管疾病。
DOI：
10.1016/j.jacc.2018.06.027
复制
发表时间：
2018
影响因子：
24
通讯作者：
Stellos,Konstantinos
中科院分区：
文献类型：
--
作者：
Stamatelopoulos,Kimon;Pol,ChristineJ;Ayers,Colby;Georgiopoulos,Georgios;Gatsiou,Aikaterini;Brilakis,EmmanouilS;Khera,Amit;Drosatos,Konstantinos;deLemos,JamesA;Stellos,Konstantinos
Amyloid-beta (1-40)(Ab40), a peptide with proinflammatory and proatherosclerotic properties, is associated with arterial aging (1) and with major adverse cardiovascular events in patients with stable coronary heart disease, heart failure, or acute coronary syndrome (1–3). However, the clinical significance of Ab40 in the general population without clinically overt cardiovascular disease (CVD) is unknown. We sought to determine the association of circulating Ab40 levels with facets of subclinical cardiac and coronary artery disease in the general population.
Amiloide beta (1-40) en sangre, cognición y pronóstico en insuficiencia hearta
影响因子：
5.9
作者：
A. Bayés;J. Barallat;Marta de Antonio;M. Domingo;E. Zamora;J. Vila;Isaac Subirana;Paloma Gastelurrutia;M. Cruz Pastor;James L. Januzzi;J. Lupón
通讯作者：
J. Lupón
影响因子：
24
作者：
Troncone, Luca;Luciani, Marco;Coggins, Matthew;Wilker, Elissa H.;Ho, Cheng-Ying;Codispoti, Kari Elise;Frosch, Matthew P.;Kayed, Rakez;del Monte, Federica
通讯作者：
del Monte, Federica